Study of Therapeutic Options for Subjects Discontinuing Efalizumab and Experiencing Disease Recurrence
Clinical trial NCT01079988 · COMPLETED
Trial details
- NCT number
- NCT01079988
- Sponsor
- Merck KGaA, Darmstadt, Germany
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2004-02-01
- Primary completion
- 2004-12-01
- Enrollment
- 41
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.